找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers in Liver Disease; Vinood B. Patel,Victor R. Preedy Reference work 2017 Springer Science+Business Media Dordrecht 2017 Applicati

[復制鏈接]
樓主: False-Negative
41#
發(fā)表于 2025-3-28 16:00:47 | 只看該作者
42#
發(fā)表于 2025-3-28 18:47:11 | 只看該作者
https://doi.org/10.1007/978-3-531-91170-0it might also be detected in muscle cells. In contrast to other markers of liver cell integrity like ASAT or Lactate Dehydrogenase, ALAT is highly specific for liver diseases. The sensitivity of elevated ALAT for hepatopathies is as high as 84% in large studies. The life span of a human liver cell i
43#
發(fā)表于 2025-3-29 02:15:05 | 只看該作者
Konsens – der Grund der Legitimit?ts of patients with liver disorders. All prognostic scores for liver diseases include bilirubin in their calculations, and some studies have shown that bilirubin is an independent biomarker of mortality risk. We know that a high total bilirubin level is an indicator of disease, but nowadays there is
44#
發(fā)表于 2025-3-29 03:36:07 | 只看該作者
45#
發(fā)表于 2025-3-29 10:53:40 | 只看該作者
46#
發(fā)表于 2025-3-29 13:55:26 | 只看該作者
47#
發(fā)表于 2025-3-29 15:58:24 | 只看該作者
48#
發(fā)表于 2025-3-29 20:03:59 | 只看該作者
Traditional Markers in Liver Disease physicians can be helped by specific markers used to diagnose and follow up liver diseases. In fact some of the enzymes and the end products of the metabolic pathway occurring in the liver are very sensitive for the abnormality occurred and, for this reason, may be considered as biochemical markers
49#
發(fā)表于 2025-3-30 00:12:14 | 只看該作者
Hepascore and Its Application to Liver Disease influences management. Histopathological staging of liver biopsy is considered the gold standard for assessment of liver fibrosis but is limited by its invasive nature, high cost, and sampling error. Hepascore is a serum model consisting of hyaluronic acid, bilirubin, alpha2-macroglobulin, gamma-gl
50#
發(fā)表于 2025-3-30 04:33:17 | 只看該作者
Model for End-Stage Liver Disease (MELD) Score as a Biomarkertive. The model for end-stage liver disease (MELD) score was developed and is an accurate biomarker of 90-day mortality in patients with ESLD, essentially measuring how sick a patient is. The MELD score incorporates serum bilirubin, creatinine, and INR in a mathematical formula. Since 2002, the MELD
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 16:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
鄂伦春自治旗| 当雄县| 泗洪县| 成安县| 凤台县| 庆云县| 泰来县| 庆安县| 临漳县| 福鼎市| 股票| 朝阳区| 临夏市| 安新县| 增城市| 静海县| 上林县| 伊宁市| 宁远县| 任丘市| 郁南县| 承德县| 尚志市| 犍为县| 曲麻莱县| 津市市| 湘西| 抚松县| 诸城市| 汝阳县| 永兴县| 中方县| 青州市| 新巴尔虎右旗| 漳州市| 青岛市| 磐石市| 安阳县| 平阳县| 米林县| 平江县|